Ionis Pharmaceuticals Inc annual operating income for fiscal TTM was -$594 million, a decrease of 55.5% from -$382 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($594M) | ($382M) | ($475M) | ($354M) | ($410M) | ($30M) | ($172M) | $366M | ($61M) | $31M | ($46M) | ($76M) | ($48M) | ($52M) | ($69M) | ($71M) | ($48M) | ($28M) | ($13M) | ($33M) | ($65M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | ($102M) | ($117M) | ($215M) | ($160M) | $140M | ($147M) | ($111M) | ($149M) | ($66M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More IONS metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All IONS financial statements → Interactive IONS charts →
About TickerBase · Data methodology & sources · Privacy · Terms